The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2018

→ Further develop a comprehensive position for Avicenna on what is needed in EU research;
→ Launch of the new Avicenna Alliance internship scheme;
→ A core focus of the VPH membership is on the FET Flagship on ageing and on shaping this Flagship programme;
→ Contribute to the three upcoming Avicenna Alliance White Papers

Working group leader:

  • Liesbet Geris
  • Executive Director, VPH Institute
  • Professor, University of Liège & KU Leuven (Belgium)

Avicenna Alliance news

EU invests €1 billion in world-class European supercomputers

The Competitiveness Council (Council of Ministers) of the European Union adopted a Regulation to establish a Joint Undertaking of European...

find out more ›

More EU Member States join the 'Genomics Declaration'

On 21 September Croatia signed to join the European declaration on genomic data sharing. The Member State follows in the footsteps of Austria and...

find out more ›

'Plan S' and 'cOAlition S': joining forces to accelerate the transition to Open Access

On 4 September, Commissioner Moedas – who is in charge of Research, Science and Innovation – announced the...

find out more ›

Show all activites